Chemiesynth (Vapi) Ltd

Chemiesynth (Vapi) Ltd has informed the stock exchange that it has sent a letter to shareholders who have not registered their email addresses, providing a weblink to the Annual Report for FY 2025-26. This action is in compliance with SEBI Listing Regulations. The letter also serves as a reminder for shareholders to update their KYC details and dematerialize physical securities as per recent SEBI circulars. The 40th Annual General Meeting is scheduled for September 30, 2026. Shareholders can access the Annual Report and update details via the company's website and RTA's portal.

Chemiesynth (Vapi) Limited has filed its Annual Report for the financial year 2025-26, in compliance with SEBI (LODR) Regulations, 2015. The report will be presented at the company's 40th Annual General Meeting (AGM) scheduled for September 30, 2026. The filing includes detailed sections on corporate information, AGM notice, Directors' Report, auditors' reports, financial statements, and related annexures covering conservation of energy, employee particulars, and management discussion and analysis. The report also provides details on the Board of Directors, auditors, registered office, committees, and share transfer agents.

Chemiesynth (Vapi) Limited has announced its 40th Annual General Meeting (AGM) for its members. The meeting is scheduled to take place on Wednesday, September 30, 2026, at 11:00 AM at the company's registered office located at Plot No. 27, GIDC, Vapi, Dist. Valsad, Gujarat. The company has also provided a detailed notice of the AGM, along with the annual report for the financial year 2025-26, which includes various sections such as Directors' Report, Auditors' Report, financial statements, and other annexures. The book closure period for the AGM is from September 24, 2026, to September 30, 2026, inclusive.

Chemiesynth (Vapi) Ltd has issued a corrigendum to its board meeting outcome dated August 12, 2026. The company is rectifying a typographical error concerning the 'Share Transfer Book Closure' and 'Benpose Date' for its 40th Annual General Meeting. The book closure dates have been revised from 23/09/2025 to 30/09/2025 to 24/09/2026 to 30/09/2026. The Benpose Date for sending AGM notices has also been corrected from 29/08/2026 to 28/08/2026. All other details from the original outcome remain unchanged.

Chemiesynth (Vapi) Ltd announced that its Board of Directors, in a meeting held on August 12, 2026, approved the standalone un-audited financial results for the quarter ended June 30, 2026. The board also approved a significant increase in the company's authorized share capital from ₹3.25 Crores to ₹18.25 Crores. This includes the issuance of up to 1,50,00,000 Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) on a private placement basis, aggregating up to ₹15 Crores, with a 5% annual dividend rate. The company also scheduled its 40th Annual General Meeting for September 30, 2026.

Chemiesynth (Vapi) Ltd announced that its Board of Directors, in a meeting held on August 12, 2026, approved the increase of authorized share capital from ₹3.25 Crores to ₹18.25 Crores. This includes an increase in equity shares and the introduction of ₹15 Crores in Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) to be issued on a private placement basis. The company also approved the draft of new Articles of Association and scheduled its 40th Annual General Meeting for September 30, 2026. The Board also noted the unaudited financial results for the quarter ended June 30, 2026, and the limited review report.

Chemiesynth (Vapi) Ltd's Board of Directors met on August 12, 2026, approving the un-audited financial results for the quarter ended June 30, 2026, along with the limited review report. A significant decision was the approval to increase the authorized share capital from ₹3.25 Crores to ₹18.25 Crores, comprising equity and preference shares. The board also greenlit the private placement issuance of up to ₹15 Crores in Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) with a 5% annual dividend. The 40th Annual General Meeting is scheduled for September 30, 2026.

Chemiesynth (Vapi) Ltd has announced a Board of Directors meeting scheduled for August 12, 2026. The primary agenda items include the consideration and approval of the Standalone Unaudited Financial Results for the quarter ended June 30, 2026, along with the limited review report. The board will also discuss and approve the Directors' Report, Management Discussion and Analysis, and other disclosures. Additionally, proposals for increasing the authorized share capital, amending the Memorandum and Articles of Association, and issuing Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) on a private placement basis will be considered. The meeting will also finalize arrangements for the 40th Annual General Meeting, including fixing the date, time, venue, and closure of the share transfer book, as well as appointing a scrutinizer and fixing cut-off dates for remote e-voting. The trading window will remain closed until 48 hours after the declaration of results.

Chemiesynth (Vapi) Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI regulations and the company's internal code of conduct. The trading window will be shut from July 01, 2026, and will reopen 48 hours after the announcement of the un-audited financial results for the quarter ending June 30, 2026. A board meeting to approve these financial statements is scheduled on or before August 14, 2026. All designated persons and their immediate relatives are prohibited from trading during this period.

Chemiesynth (Vapi) Ltd's board meeting on May 27, 2026, approved the audited financial results for the quarter and year ended March 31, 2026. The statutory auditors, M/s Manoj Shah & Co., issued an audit report with an unmodified opinion on the financial results. The meeting commenced at 3:00 PM and concluded at 4:45 PM.